Results 51 to 60 of about 382,408 (297)

Evaluation of LDH, AFP, b-hCG and tumour markers CEA and CA-125 in sera of Iraqi patients with ovarian cancer [PDF]

open access: yesScripta Medica
Background/Aim: Ovarian cancer is still a big health concern, with few early detection options. The present research aimed to explore the test's usefulness of blood levels of cancer antigen 125 (CA-125), carcinoembryonic antigen (CEA), Alpha-fetoprotein (
Jassim Dawood Yasser   +3 more
doaj   +1 more source

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors

open access: yesClinical and Translational Science, 2023
Increasing demand for glutaminase (GLS) due to high rates of glutamine metabolism is considered one of the hallmarks of malignancy. In parallel, cancer antigen 125 (CA‐125) is a commonly used ovarian tumor marker. This study aimed to compare the roles of
Gatot Nyarumenteng Adhipurnawan Winarno   +9 more
doaj   +1 more source

Novel CA-125 antigen determination in serum by electrochemical methods with onion oil-containing organo-hydrogels

open access: yesMANAS: Journal of Engineering, 2023
CA-125 antigen is a glycoprotein that can be found at distinct levels in blood samples according to the phases of ovarian cancer. Herein, we designed novel onion oil-organo-hydrogels (OOHGs) to detect CA-125 antigen at high sensitivity and selectively ...
Duygu Alpaslan   +3 more
doaj   +1 more source

Hubungan Tumor Marker Ca-125 Dengan Sifat Dan Tipe Sel Tumor Ovarium Di RSUD Arifin Achmad Pekanbaru [PDF]

open access: yes, 2014
Ovarian tumor caused by inflammation or proliferation of ovarian's ephitelial, germinal, stroma cell and it can be benign and Malignant. Ovarian tumor had many tumor markers, the most known is Cancer Antigen 125 (CA-125).
Fatmawati, F. (Fatmawati)   +2 more
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Carbohydrate Antigen-125

open access: yesJACC: Case Reports
Background: Carbohydrate antigen-125 (also known as cancer antigen-125) (CA-125) is a biomarker used to monitor for endometrial cancer progression, but it may also reflect other disease processes.
Vijay U. Rao, MD, PhD   +5 more
doaj   +1 more source

libtissue - implementing innate immunity [PDF]

open access: yes, 2006
In a previous paper the authors argued the case for incorporating ideas from innate immunity into articficial immune systems (AISs) and presented an outline for a conceptual framework for such systems.
Aickelin, Uwe, Twycross, Jamie
core   +3 more sources

TMC4 localizes to multiple taste cell types in the mouse taste papillae

open access: yesFEBS Open Bio, EarlyView.
Transmembrane channel‐like 4 (TMC4), a voltage‐dependent chloride channel, plays a critical role in amiloride‐insensitive salty taste transduction. TMC4 is broadly expressed in all mature taste cell types, suggesting a possible involvement of multiple cell types in this pathway.
Momo Murata   +6 more
wiley   +1 more source

Primary Malignant Mesothelioma of the Peritoneum Mistaken for Peritoneal Tuberculosis due to Elevated Cancer Antigen 125

open access: yesThe Korean Journal of Gastroenterology, 2019
A differential diagnosis of ascites is always challenging for physicians. Peritoneal tuberculosis is particularly difficult to distinguish from peritoneal carcinomatosis because of the similarities in clinical manifestations and laboratory results ...
Ju Hyun Oh, Myung Jin Oh
doaj   +1 more source

T-Cell activation: a queuing theory analysis at low agonist density [PDF]

open access: yes, 2006
We analyze a simple linear triggering model of the T-cell receptor (TCR) within the framework of queuing theory, in which TCRs enter the queue upon full activation and exit by downregulation.
Wedagedera, J. R., Burroughs, Nigel John
core   +1 more source

Home - About - Disclaimer - Privacy